Relationship between C-reactive protein and atherosclerotic risk factors and oxidative stress markers among young persons 10-18 years old

Clinical Chemistry

Volumn 53, Issue 3, 2007, Pages 456-464

  Kelishadi, Roya ^a   Sharifi, Mohsen ^b   Khosravi, Alireza ^a   Adeli, Khosrow ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKADIENE; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; BODY FAT DISTRIBUTION; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; SCHOOL CHILD;

ADIPOSE TISSUE; ADOLESCENT; ANTHROPOMETRY; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHILD; FEMALE; HUMANS; LIPIDS; MALE; MALONDIALDEHYDE; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; RISK FACTORS;

EID: 33947416103     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.073668     Document Type: Article

References (39)

1. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 2003;107:391-7.
2. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.
3. Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 2000;149:139-50.
4. Barbeu P, Litaker MS, Woods KF, Lemmon CR, Humphries MC, Owen S, et al. Haemostatic and inflammatory markers in obese youths: effects of exercise and adiposity. J Pediatr 2002;141: 415-20.
5. Kelishadi R, Nadery GA, Asgary S. Oxidized LDL metabolites with high family risk for premature cardiovascular disease. Indian J Pediatr 2002;69:755-9.
6. Abramson JL, Hooper WC, Jones DP, Ashfaq S, Rhodes SD, Weintraub WS, et al. Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis 2005;178:115-21.
7. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics 1996;98: 649-58.
8. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
9. Chajes V, Sattlre W, Stultschnig M, Kostner G. Photometric evaluation of lipid peroxidation products in human plasma and copper oxidized low density lipoproteins: correlation of different oxidation parameters. Atherosclerosis 1996;121:193-203.
10. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4 hydroxynonenal. Meth Enzymol 1990;186:407-21.
11. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004;110:2494-7.
12. Genuth, S, Alberti, KG, Bennett, P, Buse J, Defronzo R, Kahn R, et al., Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-7.
13. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM. CDC growth charts: United States. Adv Data 2000;314:1-27.
14. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, HaffnerSM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-7.
15. Vikram NK, Misra A, Dwivedi M, Sharma R, Pandey RM, Luthra K, et al. Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adult in urban North India. Atherosclerosis 2003;168: 305-13.
16. Vikram NK, Misra A, Pandey RM, Dwivedi M, Luthra K. Adiponectin, insulin resistance, and C-reactive protein in postpubertal Asian Indian adolescents. Metabolism 2004;53:1336-41.
17. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-61.
18. Suzuki K, Inoue T, Hioki R, Ochiai J, Kusuhara Y, Ichino N, et al. Association of abdominal obesity with decreased serum levels of carotenoids in a healthy Japanese population. Clin Nutr 2006;25: 780-9.
19. Zieske AW, Tracy RP, McMahan CA, Herderick EE, Homma S, Malcom GT, et al; Pathobiological Determinants of Atherosclerosis in Youth Research Group. Elevated serum C-reactive protein levels and advanced atherosclerosis in youth. Arterioscler Thromb Vasc Biol 2005;25:1237-43.
20. Kobayashi S, Inoue N, Ohashi Y, Terashima M, Matsui K, Mori T, et al. Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein. Arterioscler Thromb Vasc Biol 2003;23:1398-404.
21. Ece A, Gurkan F, Kervancioglu M, Kocamaz H, Gunes A, Atamer Y, et al. Oxidative stress, inflammation and early cardiovascular damage in children with chronic renal failure. Pediatr Nephrol 2006;21:545-52.
22. Atabek ME, Vatansev H, Erkul I. Oxidative stress in childhood obesity. J Pediatr Endocrinol Metab 2004;17:1063-8.
23. Atabek ME, Keskin M, Yazici C, Kendirci M, Hatipoglu N, Koklu E, et al. Protein oxidation in obesity and insulin resistance. Eur J Pediatr 2006;165:753-6.
24. Erdeve O, Siklar Z, Kocaturk PA, Dallar Y, Kavas GO. Antioxidant superoxide dismutase activity in obese children. Biol Trace Elem Res 2004;98:219-28.
25. Engler MM, Engler MB, Malloy MJ, Chiu EY, Schloetter MC, Paul SM, et al. Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY)Trial. Circulation 2003;108: 1059-63.
26. Tsimikas S. Measures of oxidative stress. Clin Lab Med 2006; 26:571-90.
27. Aziz J, Siddiqui NA, Siddiqui IA, Omair A. Relation of body mass index with lipid profile and blood pressure in young healthy students at Ziauddin Medical University. J Ayub Med Coll Abbottabad 2003;15:57-9.
28. Kahraman S, Yilmaz R, Akinci D, Arici M, Altun B, Erdem Y, et al. U-shaped association of body mass index with inflammation and atherosclerosis in hemodialysis patients. J Ren Nutr 2005;15: 377-86.
29. Klass DM, Buhrmann K, Sauter G, Del Puppo M, Scheibner J, Fuchs M, et al. Biliary lipids, cholesterol and bile synthesis: different adaptive mechanisms to dietary cholesterol in lean and obese subjects. Aliment Pharmacol Ther 2006;23:895-905.
30. Manios Y, Dimitriou M, Moschonis G, Kocaoglu B, Sur H, Keskin Y, et al. Cardiovascular disease risk factors among children of different socioeconomic status in Istanbul, Turkey: directions for public health and nutrition policy. Lipids Health Dis 2004;3:11.
31. Kelishadi R, Pour MH, Zadegan NS, Kahbazi M, Sadry G, Amani A, et al. Fat intake and serum lipid profile in Iranian adolescents: IHHP-HHPC. Prev Med 2004;39:760-6.
32. Nakanishi N, Shiraishi T, Wada M. Association between C-reactive protein and insulin resistance in a Japanese population: the Minoh Study. Intern Med 2005;44:542-7.
33. Festa A, D'Agostino R Jr, Tracy RP, Haffner SM. C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study. Diabet Med 2002;19:939-43.
34. McLaughlin T, Abbasi F, Lamendola C, Liang L, Reaven G, Schaaf P, et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 2002;106: 2908-12.
35. Florez H, Castillo-Florez S, Mendez A, Casanova-Romero P, Larreal-Urdaneta C, Lee D, et al. C-reactive protein is elevated in obese patients with the metabolic syndrome. Diabetes Res Clin Pract 2006;71:92-100.
36. Ford ES, Ajani UA, Mokdad AH; National Health and Nutrition Examination. The metabolic syndrome and concentrations of C-reactive protein among U. S. youth. Diabetes Care 2005;28:878-81.
37. Garanty-Bogacka B, Syrenicz M, Syrenicz A, Gebala A, Walczak M. Relation of acute-phase reaction and endothelial activation to insulin resistance and adiposity in obese children and adolescents. Neuro Endocrinol Lett 2005;26:473-9.
38. Moran A, Steffen LM, Jacobs DR Jr, Steinberger J, Pankow JS, Hong CP, et al. Relation of C-reactive protein to insulin resistance and cardiovascular risk factors in youth. Diabetes Care 2005;28:1763-8.
39. Kelishadi R, Gheiratmand R, Ardalan G, Adeli K, Mehdi Gouya M, Mohammad Razaghi E, et al; for the CASPIAN Study Group. Association of anthropometric indices with cardiovascular disease risk factors among children and adolescents: CASPIAN Study. Int J Cardiol. 2006 Jul 19; [Epub ahead of print]